Research Article| Volume 6, ISSUE 4, P167-172, April 1997

Download started.


Emerging risk factors for stroke: Patent foramen ovale, proximal aortic atherosclerosis, antiphospholipid antibodies, and activated protein C resistance

  • Jeffrey L. Saver
    Address reprint requests to Jeffrey L. Saver, MD, UCLA Stroke Center, Reed Neurologic Research Center, 710 Westwood Plaza, Los Angeles, CA 90095.
    Department of Neurology, UCLA Stroke Center, UCLA Medical Center, Los Angeles, CA., USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Sacco RL
        • Homma S
        • Di Tullio MR
        Patent foramen ovale: A new risk factor for ischemic stroke.
        Heart Dis Stroke. 1993; 2: 235-241
        • Cohnheim J.
        Handbuch für Artze und Studierende. Hirshwald, Berlin1877
        • Nighoghossian N
        • Perinetti M
        • Barthelet M
        • Adeline P
        • Trouillas P
        Transesophageal echocardiography in patients less than 60 years of age without obvious cardiac source of embolism.
        Neurol Res. 1994; 17: 368-372
        • Stollberger C
        • Slany J
        • Schuster I
        • et al.
        The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism.
        Ann Intern Med. 1993; 119: 461-465
        • Cabanes L
        • Mas JL
        • Cohen A
        • et al.
        Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography.
        Stroke. 1993; 24: 1865-1873
        • Homma S
        • Di Tullio MR
        • Sacco R
        • et al.
        Characteristics of patent foramen ovale associated with cryptogenic stroke.
        Stroke. 1994; 25: 582-586
        • Stone DA
        • Godard J
        • Corretti MC
        • et al.
        Patent foramen ovale: association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events.
        Am Heart J. 1996; 131: 158-161
        • Ende DJ
        • Chopra PS
        • Rao PS
        Transcatheter closure of atrial septal defect or patent foramen ovale with the buttoned device for prevention of reccurrence of paradoxical embolism.
        Am J Cardiol. 1996; 78: 233-236
        • French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm
        Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack.
        Am Heart J. 1995; 130: 1083-1088
        • Toyada K
        • Yasaka M
        • Nagata S
        • Yamaguchi T
        Aortogenic embolic stroke: A transesophageal echocardiographic approach.
        Stroke. 1992; 23: 1056-1061
        • Amarenco P
        • Duyckaerts C
        • Tzourio C
        • Henin D
        • Bousser M-G
        • Hauw J-J
        The prevalence of ulcerated plaques in the aortic arch in patients with stroke.
        N Engl J Med. 1992; 326: 221-225
        • Amarenco P
        • Cohen A
        • Tzourio C
        • et al.
        Atherosclerotic disease of the aortic arch and the risk of ischemic stroke.
        N Engl J Med. 1994; 331: 1474-1479
        • Jones EF
        • Kalman JM
        • Calafiore P
        • Tonkin AM
        • Donnan GA
        Proximal aortic atheroma. An independent risk factor for cerebral ischemia.
        Stroke. 1995; 26: 218-224
        • Katz ES
        • Tunick PA
        • Rusinek H
        • Ribakove G
        • Spencer FC
        • Kronzon I
        Protruding aortic atheromas predict stroke in elderly patients undergoing cardiopulmonary bypass.
        J Am Coll Cardiol. 1992; 20: 70-77
        • French Study of Aortic Plaques in Stroke Group
        Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke.
        N Engl J Med. 1996; 334: 1216-1221
        • Hilton TC
        • Menke D
        • Blackshear JL
        Variable effect of anticoagulation in the treatment of severe protruding atherosclerotic aortic debris.
        Am Heart J. 1995; 127: 1645-1647
        • Swanson SJ
        • Cohn LH
        Excision of focal aortic arch atheroma using deep hypothermic circulatory arrest.
        Ann Thorac Surg. 1995; 60: 457-458
        • Geschwind DH
        • FizPatrick M
        • Mischel PS
        • Cummings JL
        Sneddon's syndrome is a thrombotic vasculopathy: neuropathologic and neuroradiologic evidence.
        Neurology. 1995; 45: 557-560
        • Antiphospholipid Antibodies in Stroke Study Group
        Anticardiolipin antibodies are an independent risk factor for first ischemic stroke.
        Neurology. 1993; 43: 2069-2073
        • Khamashta MA
        • Cuadrado MJ
        • Mujic F
        • Taub NA
        • Hunt BJ
        • Hughes GRV
        The management of thrombosis in the antiphospholipid-antibody syndrome.
        N Engl J Med. 1995; 332: 993-997
        • Levine SR
        • Brey RL
        • Sawaya KL
        • et al.
        Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome.
        Ann Neurol. 1995; 38: 119-124
        • Rosove M
        • Brewer P
        Antiphospholipid thrombosis: clinical course after first thrombotic event in 70 patients.
        Ann Intern Med. 1992; 117: 303-308
        • Barinagarrementeria F
        • Cantu-Brito C
        • De La Pena A
        • Izaguirre R
        Prothrombotic states in young people with idiopathic stroke: a prospective study.
        Stroke. 1994; 25: 287-290
        • Dahlback B
        Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thrombosis.
        Blood. 1995; 85: 607-614
        • Zuber M
        • Toulon P
        • Marnet L
        • Mas J-L
        Factor V Leiden mutation in cerebral venous thrombosis.
        Stroke. 1996; 27: 1721-1723
        • Martinelli I
        • Landi G
        • Merati G
        • Cella R
        • Tosetto A
        • Mannucci PM
        Factor V gene mutation is a risk factor for cerebral venous thrombosis.
        Thromb Haemost. 1996; 75: 393-394
        • Ridker PM
        • Hennekens CH
        • Lindpaintner K
        • Stampfer MJ
        • Eisenberg PR
        • Miletich JP
        Mutation in the gene coding for coagulation V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men.
        N Engl J Med. 1995; 332: 912-917
        • Catto A
        • Carter A
        • Ireland H
        • et al.
        Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke.
        Arterioscler Thromb Vasc Biol. 1995; 15 (PR): 783-785
        • Halbmayer W-M
        • Haushofer A
        • Schon R
        • Fischer M
        The prevalence of poor anticoagulant response to protein C (APC resistance) among patients suffering from stroke or venous thrombosis and healthy subjects.
        Blood Coag Fibrinol. 1994; 5: 51-57
        • Forsyth PD
        • Dolan G
        Activated protein C resistance in cases of cerebral infarction.
        Lancet. 1995; 345: 795
        • van der Bom JG
        • Bots ML
        • Haverkate F
        • et al.
        Reduced response to activated protein C is associated with increased risk for cerebrovascular disease.
        Ann Intern Med. 1996; 125: 265-269
        • Fisher M
        • Fernandez JA
        • Ameriso SF
        • Xie D
        • Gruber A
        • Paganini-Hill A
        • Griffin JH
        Activated protein C resistance in ischemic stroke not due to factor V arginine506→glutamine mutation.
        Stroke. 1996; 27: 1163-1166